Skip to main content

[]

Intended for healthcare professionals
Skip to main content
Restricted access
Research article
First published online November 5, 2018

Are there patients missing from community heart failure registers? An audit of clinical practice

Abstract

Background

General practitioners in the UK are financially incentivised, via the Quality Outcomes Framework, to maintain a record of all patients at their practice with heart failure and manage them appropriately. The prevalence of heart failure recorded in primary care registers (0.7–1.0%) is less than reported in epidemiological studies (3–5%). Using an audit of clinical practice, we set out to investigate if there are patients ‘missing’ from primary care heart failure registers and what the underlying mechanisms might be.

Design

The design of this study was as an audit of clinical practice at a UK general practice (n = 9390).

Methods

Audit software (ENHANCE-HF) was used to identify patients who may have heart failure via a series of hierarchical searches of electronic records. Heart failure was then confirmed or excluded based on the electronic records by a heart failure specialist nurse and patients added to the register. Outcome data for patients without heart failure was collected after two years.

Results

Heart failure prevalence was 0.63% at baseline and 1.12% after the audit. Inaccurate coding accounted for the majority of missing patients. Amongst patients without heart failure who were taking a loop diuretic, the rate of incident heart failure was 13% and the rate of death or hospitalization with heart failure was 25% respectively during two-year follow-up.

Conclusion

There are many patients missing from community heart failure registers which may detriment patient outcome and practice income. Patients without heart failure who take loop diuretics are at high risk of heart failure-related events.

Get full access to this article

View all access and purchase options for this article.

References

1. Galasko GI, Senior R, Lahiri A. Ethnic differences in the prevalence and aetiology of left ventricular systolic dysfunction in the community: The Harrow heart failure watch. Heart 2005; 91: 595–600.
2. Hedberg P, Lonnberg I, Jonason T, et al. Left ventricular systolic dysfunction in 75-year-old men and women; a population-based study. Eur Heart J 2001; 22: 676–683.
3. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991; 121: 951–957.
4. Yousaf F, Collerton J, Kingston A, et al. Prevalence of left ventricular dysfunction in a UK community sample of very old people: The Newcastle 85 + study. Heart 2012; 98: 1418–1423.
5. Yancy CW, Lopatin M, Stevenson LW, et al. ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: A report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006; 47: 76–84.
6. Fonarow GC, Stough WG, Abraham WT, et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: A report from the OPTIMIZE-HF registry. J Am Coll Cardiol 2007; 50: 768–777.
7. van Riet EE, Hoes AW, Wagenaar KP, et al. Epidemiology of heart failure: The prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail 2016; 18: 242–252.
8. Cooper LB, DeVore AD, Felker GM. The impact of worsening heart failure in the United States. Heart Fail Clin 2015; 11: 603–614.
9. Sahle BW, Owen AJ, Krum H, et al. Incidence of heart failure in 6083 elderly hypertensive patients: The Second Australian National Blood Pressure Study (ANBP2). Eur J Heart Fail 2016; 18: 38–45.
10. Guha K, McDonagh T. Heart failure epidemiology: European perspective. Curr Cardiol Rev 2013; 9: 123–127.
11. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 2016; 18: 891–975.
13. NHS Digital. Quality and outcomes framework (QOF) – 2014-15, http://content.digital.nhs.uk/catalogue/PUB18887 (2015, accessed 26 October 2016).
14. van Riet EE, Hoes AW, Limburg A, et al. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur J Heart Fail 2014; 16: 772–777.
15. Public Health England. National General Practice Profiles, https://fingertips.phe.org.uk/profile/general-practice (accessed 8 August 2018).
16. Williams A, Fay M. ENHANCE HF™: Optimising the management of heart failure in primary care. PCCJ 2014; 7: 134.
17. Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, Lisinopril, on morbidity and mortality in chronic heart failure. Circulation 1999; 100: 2312–2318.
18. Konstam MA, Neaton JD, Dickstein K, et al. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): A randomised, double-blind trial. Lancet 2009; 374: 1840–1848.
19. Fiuzat M, Wojdyla D, Kitzman D, et al. Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: Results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial. J Am Coll Cardiol 2012; 60: 208–215.
20. Pellicori P, Kaur K, Clark AL. Fluid management in patients with chronic heart failure. Card Fail Rev 2015; 1: 90–95.
21. Baranowski PJ, Peterson KL, Statz-Paynter JL, et al. Incidence and cost of medications dispensed despite electronic medical record discontinuation. J Am Pharm Assoc 2015; 55: 313–319.
22. Rhodes KE. Prescription of diuretic drugs and monitoring of long-term use in one general practice. Br J Gen Pract 1992; 42: 68–70.
23. Wehling M. Morbus diureticus in the elderly: Epidemic overuse of a widely applied group of drugs. J Am Med Dir Assoc 2013; 14: 437–442.
24. Davis BR, Kostis JB, Simpson LM, et al. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Circulation 2008; 118: 2259–2267.
25. Zaman S, Zaman SS, Scholtes T, et al. The mortality risk of deferring optimal medical therapy in heart failure: A systematic comparison against norms for surgical consent and patient information leaflets. Eur J Heart Fail 2017; 19: 1401–1409.
26. Burey L and Spence M. Greater Manchester heart failure investigation tool: Primary care heart failure project. Greater Manchester Collaboration for Leadership in Applied Health Research and Care. Salford Royal NHS Foundation Trust, 2011, https://www.clahrc-gm.nihr.ac.uk/media/wpweb/GM-HFIT-Primary-Care-Heart-Failure-Project-Full-Report.pdf.
27. Valk MJ, Mosterd A, Broekhuizen, et al. Over diagnosis of heart failure in primary care: A cross sectional study. Br J Gen Pract 2016; 66: e587–e592.
28. Griffo R, Spanevello A, Temporelli PL, et al. SUSPIRIUM Investigators. Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey. Eur J Prev Cardiol 2017; 24: 567–576.
29. Boonman-de Winter LJ, Rutten FH, Cramer MJ, et al. Efficiently screening heart failure in patients with type 2 diabetes. Eur J Heart Fail 2015; 17: 187–195.
30. Albert NM, Fonarow GC, Yancy CW, et al. Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: Findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Am Heart J 2010; 159: 238–244.

Cite article

Cite article

Cite article

OR

Download to reference manager

If you have citation software installed, you can download article citation data to the citation manager of your choice

Share options

Share

Share this article

Share with email
Email Article Link
Share on social media

Share access to this article

Sharing links are not relevant where the article is open access and not available if you do not have a subscription.

For more information view the Sage Journals article sharing page.

Information, rights and permissions

Information

Published In

Article first published online: November 5, 2018
Issue published: February 2019

Keywords

  1. Chronic heart failure
  2. diuretics
  3. general practice
  4. pharmacological management

Rights and permissions

© The European Society of Cardiology 2018.
Request permissions for this article.

History

Manuscript received: January 24, 2018
Manuscript accepted: October 13, 2018
Published online: November 5, 2018
Issue published: February 2019
PubMed: 30396291

Authors

Affiliations

Joseph J Cuthbert
Department of Academic Cardiology, Hull York Medical School, UK
Jayanthi Gopal
Montague Health Centre, UK
Amanda Crundall-Goode
Department of Academic Cardiology, Hull York Medical School, UK
Andrew L Clark
Department of Academic Cardiology, Hull York Medical School, UK

Notes

Joseph J Cuthbert, Hull York Medical School, Daisy Building, Castle Hill Hospital, Hull, East Yorkshire HU16 5JQ, UK. Email: [email protected]

Author Contribution

JG, AC-G and ALC contributed to the conception and design and JJC contributed to the design of the study. Data was collected by JJC, JG and AC-G, data was analysed by JJC and the manuscript was drafted by JJC and ALC.

Metrics and citations

Metrics

Journals metrics

This article was published in .

View All Journal Metrics

Article usage*

Total views and downloads: 163

*Article usage tracking started in December 2016


Articles citing this one

Receive email alerts when this article is cited

Web of Science: 8 view articles Opens in new tab

Crossref: 11

  1. Heart failure and microvascular dysfunction: an in-depth review of mechanisms, diagnostic strategies, and innovative therapies
    Go to citationCrossrefGoogle Scholar
  2. Characteristics and outcomes of patients with heart failure with preserved ejection fraction referred to a community specialist nurse-led clinic
    Go to citationCrossrefGoogle Scholar
  3. Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study
    Go to citationCrossrefGoogle Scholar
  4. Informing understanding of coordination of care for patients with heart failure with preserved ejection fraction: a secondary qualitative analysis
    Go to citationCrossrefGoogle Scholar
  5. Mixed‐methods evaluation of a multifaceted heart failure intervention in general practice: the OSCAR‐HF pilot study
    Go to citationCrossrefGoogle Scholar
  6. How can we improve the diagnosis of heart failure?
    Go to citationCrossrefGoogle Scholar
  7. Optimal Management of Heart Failure and Chronic Obstructive Pulmonary Disease: Clinical Challenges
    Go to citationCrossrefGoogle Scholar
  8. Diagnosis of patients with heart failure with preserved ejection fraction in primary care: cohort study
    Go to citationCrossrefGoogle Scholar
  9. Characteristics of patients with heart failure with preserved ejection fraction in primary care: a cross-sectional analysis
    Go to citationCrossrefGoogle Scholar
  10. Age old problem: heart failure treatment in elderly
    Go to citationCrossrefGoogle ScholarPub Med
  11. View More

Figures and tables

Figures & Media

Tables

View Options

Access options

If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:

ESC members can access this journal content using society membership credentials.

ESC members can access this journal content using society membership credentials.


Alternatively, view purchase options below:

Access journal content via a DeepDyve subscription or find out more about this option.

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text